Here, we demonstrated that CCL21/CCR7 contributed to the time-dependent proliferation of human NSCLC cells by upregulating the expression of cyclin A, cyclin B1, and CDK1 via the ERK pathway. Here, CCR7 is linked to non-small cell lung carcinoma.